This site is intended for healthcare professionals only
LoginRegister
CDSCO Panel Directs Malik Lifesciences to Revise Phase III Trial Protocol for Tamsulosin, Dutasteride, Tadalafil FDCCDSCO Panel Directs Malik Lifesciences to Revise Phase III Trial Protocol for Tamsulosin,...
Zydus Lifesciences Dr Sharvil Patel takes over as IPA PresidentZydus Lifesciences Dr Sharvil Patel takes over as IPA President
Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 croreBangalore-based Indegene acquires BioPharm from Omnicom Health Group
ZydusZydus's Sentynl Therapeutics pediatric Menkes disease drug flagged by USFDA
Rajasthan Health Dept debunks cough syrup death rumoursRajasthan Health Dept debunks cough syrup death rumours
Roche Drops Muscle Disease Drug After Trial FailureRoche bags USFDA nod for Tecentriq plus lurbinectedin for extensive-stage small cell lung cancer
DoP invites applications for research, innovation projects under PRIP schemeDoP invites applications for research, innovation projects under PRIP scheme
Lupin: Manufacturing Operations President Rajendra Chunodkar retiresLupin: Manufacturing Operations President Rajendra Chunodkar retires
Lupin Gets Zero USFDA Observations for Nagpur PlantLupin unveils Rivaroxaban for Oral Suspension in US following USFDA approval
Bombay High Court Permits Re-Export of Seized Cosmetic Consignments Imported by GlamstoneBombay HC Grants Relief to Sun Pharma in Trademark Battle Over Lupride
Probe Launched Against Rajasthan Pharma Firm Over Dextromethorphan Syrup-Linked DeathProbe Launched Against Rajasthan Pharma Firm Over Dextromethorphan Syrup-Linked Death
Novartis declares positive results from phase III study for new malaria treatmentNovartis Rhapsido gets USFDA nod for chronic spontaneous urticaria
X